{
  "docId": "019de076-341d-707d-8f10-e094a3d9771c",
  "docSlug": "c0c2a81b97260bf20014943df2470872",
  "documentTitle": "Equillium | Investor Presentation Deck | 39 slides",
  "authorId": "equillium",
  "authorName": "Equillium",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 39,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a four-column layout to explain the target, the molecule structure, the mechanism of action, and the current clinical status.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/28",
  "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c",
  "deckJsonHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c.json",
  "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.94,
        "x": 0.03,
        "y": 0.21
      },
      "kind": "callout",
      "text": "IL-15 & IL-21 are key cytokines driving GI inflammation in celiac disease and IBD",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d3c0129d-3f90-460a-aa1e-ca15cc47a244",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.12,
        "y": 0.94
      },
      "kind": "disclaimer",
      "text": "GI = gastrointestinal; IBD = inflammatory bowel disease; CeD = celiac disease; SAD = single ascending dose; MAD = multiple ascending dose\n1) Sarra et al., Mucosal Immunol, 2013; 2) Kooy-Winkelaar et al., Gut, 2016; 3) Ciszewski et al., Gastroenterology, 2020",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3ccdae5-15b4-480c-9fbe-6aaa5f995de0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.22,
        "x": 0.03,
        "y": 0.54
      },
      "kind": "list",
      "text": "Natural biological synergy of IL-15 and IL-21 (T and B cell biology)\nIL-15 a validated target in the treatment of celiac disease",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10a7bfae-8c40-4b6a-bcc6-a4d9bf393619",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.22,
        "x": 0.53,
        "y": 0.54
      },
      "kind": "list",
      "text": "Inhibits the IL-15 & IL-21 induced signaling pathways in CeD patient-derived T cells organoid cultures that are key for tissue destruction\nPrevents intestinal tissue damage in a humanized mouse model of GI inflammation",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "91d17d76-9056-41a3-8196-1f607a23468b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.22,
        "x": 0.28,
        "y": 0.54
      },
      "kind": "list",
      "text": "PEGylated peptide based on the D-helix of γc cytokines selectively inhibiting IL-15 & IL-21 signaling\nAdministered as subcutaneous injection",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aebb82ef-4826-423c-9cf1-cb74e0b74ea1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.18,
        "x": 0.78,
        "y": 0.54
      },
      "kind": "list",
      "text": "Currently in a Phase 1 first-in-human SAD/MAD study",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cbff53ae-3924-4a8d-8247-1587d3b127ec",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.03,
        "y": 0.07
      },
      "kind": "title",
      "text": "EQ102: A First-in-class Bi-Specific Cytokine Inhibitor",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aefe9e82-519d-4042-acbf-8a74b5917bfb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}